What is ImmunityBio, Inc.'s investment proceeds?

ImmunityBio, Inc. (IBRX) reported investment proceeds of $79.38M in Q1 2026.

How has ImmunityBio, Inc.'s investment proceeds changed year-over-year?

ImmunityBio, Inc.'s investment proceeds increased by 1383.8% year-over-year, from $5.35M to $79.38M.

What is the long-term trend for ImmunityBio, Inc.'s investment proceeds?

Over 3 years (2021 to 2024), ImmunityBio, Inc.'s investment proceeds has grown at a 27.2% compound annual growth rate (CAGR), from $56.17M to $115.59M.

What does investment proceeds mean?

Cash received from sales, maturities, and redemptions of investment securities across all categories.

ImmunityBio, Inc. IBRX Investment Proceeds

Investment Proceeds at other companies

Summit TherapeuticsSMMT

$177.29M+10.4%

IncyteINCY

$0-100%

ModernaMRNA

$602M-12.5%

United TherapeuticsUTHR

$1.31B—

Kymera TherapeuticsKYMR

——

Protagonist TherapeuticsPTGX

——

Other financials

Income statement

See full

Revenue$44.2M+168%

Gross profit$44.0M+167%

Operating income-$69.8M-8.3%

Net income-$632.8M-388%

EPS (diluted)-$0.62-313%

Balance sheet

See full

Cash & equivalents$205.2M+238%

Total debt$445.4M+32.2%

Total equity-$870.0M-47.1%

Total assets$646.6M+113%

Cash flow

See full

Operating cash flow-$75.4M+12.3%

CapEx$1.8M+58.4%

Free cash flow-$77.1M+11.4%

Valuation

See full

Market cap$7.71B+208%

Enterprise value$7.95B+187%

P/S54.7×-25.4×

Profitability

See full

Gross margin99.3%-0.5pp

Operating margin-185.4%-83.3pp

Net margin-606.2%-212pp

FCF margin-212%-95.8pp

Returns & leverage

See full

Return on equity-119.3%—

Debt / equity0.1×—

Current ratio6.7×+4.4×

Where this comes from

Reported directly by ImmunityBio, Inc. in its filing.

Tagged under the XBRL concept us-gaap:ProceedsFromMaturitiesPrepaymentsAndCallsOfAvailableForSaleSecurities.

The official record: ImmunityBio, Inc.’s 10-Q, filed May 7, 2026, on SEC EDGAR. View the filing →

Ask your AI about ImmunityBio, Inc.'s investment proceeds.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI

Claude

Questions, answered.

What is ImmunityBio, Inc.'s investment proceeds?: ImmunityBio, Inc. (IBRX) reported investment proceeds of $79.38M in Q1 2026.
How has ImmunityBio, Inc.'s investment proceeds changed year-over-year?: ImmunityBio, Inc.'s investment proceeds increased by 1383.8% year-over-year, from $5.35M to $79.38M.
What is the long-term trend for ImmunityBio, Inc.'s investment proceeds?: Over 3 years (2021 to 2024), ImmunityBio, Inc.'s investment proceeds has grown at a 27.2% compound annual growth rate (CAGR), from $56.17M to $115.59M.
What does investment proceeds mean?: Cash received from sales, maturities, and redemptions of investment securities across all categories.